As evidenced by scRNA-seq profiles of normal tissues, SPINK1 is most prominently expressed in the pancreas, but nearly undetectable in the colon, liver, rectum, small intestine and stomach44, making it an attractive target for cancer therapeutic targeting. This evidence concerns the gene SPINK1 and cancer.